In 2018, the global market for Real-time PCR and Digital PCR was valued at USD 2.25 Billion. The market is expected to grow at 8.5% CAGR over the forecast period. The growth is expected to be driven by the high prevalence of target diseases as well as rapid technological advances such the development of high-performance and superior qPCR/dPCR systems.
According to the World Health Organization, cancer was the leading cause of death in 2018, accounting for 9.6 millions deaths. According to the WHO, 36.9 Million people were infected by HIV in 2017. The WHO also stated that infective diseases were the leading cause of death worldwide in 2016. These diseases are expected to rise in the near future, which will drive the market.
The PCR industry is likely to continue its efforts to create new systems and tools for molecular testing. QIAGEN N.V., for instance, announced in January 2019 its plans to develop next-generation dPCR system, which is expected to launch in 2020. These new systems will offer a significantly faster turnaround time and highly automated workflows than current digital PCR platforms, which is likely to give the company a competitive advantage.
A wide range of applications for qPCR/dPCR technologies will also increase their adoption in a variety of scientific disciplines. These technologies can be used in basic and clinical research. They are used extensively in areas such as human genetic testing and forensic sciences, pathogen detection and infectious disease testing. The market is expected to grow with new applications in food microbiology, veterinary medicine and other industries.
The market segments for Real-time PCR and Digital PCR are based on technology. They can be divided into digital and quantitative. In 2018, quantitative PCR accounted for the largest value share. The segment is expected to grow due to continued demand in areas like genetic variation analysis, gene transcription analysis, and genotyping, as well as a growing focus on Point of Care (POC), platforms.
Digital PCR, a next-generation method for analyzing nucleic acid samples, is an accurate and reliable testing tool. These systems are expected to see strong growth in the segment during the forecast period due to their superior sensitivity, accuracy, and precision compared to other PCR-based methods.
The market can be divided by product into consumables, reagents and instruments, software and services, and software and other services. In 2018, the market's largest value share was held by consumables and other reagents. This segment is expected to see a stronger growth rate than other segments due to the introduction of new PCR testing kits.
In October 2017, AOAC International, an independent standards-developing organization, certified Bio-Rad Laboratories iQ Check (Real Time PCR Kit) to be the Official Method for Analysis for Salmonella species detection from raw meat. This validation opened the door to the use of the kit for a variety of industrial purposes in the meat industry.
The market can be divided by application into clinical, research, forensic and other segments. In 2018, the research segment was dominant. qPCR and other dPCR systems were widely used in research applications like stem cell research, genetic disease and oncology research.
These systems are widely used due to their increased specificity and faster turnaround times. Due to increasing adoption of automated processes, the clinical application segment will see the highest CAGR of 8.7% over the forecast period.
The launch of new test kits and systems by PCR manufacturers in 2018 made North America the leader in the region segment. In September 2018, Thermo Fisher Scientific Inc. introduced VetMAX MastiType in qPCR-based testing that can be used to quickly detect mastitis-causing pathogens within dairy herds. The strong presence of major PCR companies in the region and increasing demand for quick diagnostic tests are expected to also drive regional growth during the forecast period.
Asia Pacific will likely see the fastest CAGR at 11.1% over the forecast period. The market is expected to grow due to a rising number of patients with chronic and infectious diseases. This will also be reflected in an increase in demand for PCR products.
To maintain their competitiveness, major market players have focused on strategic business measures. These key actions include product launches, collaborations with companies and institutes, as well as mergers and acquisitions.
QIAGEN N.V., for example, announced in January 2019 that it had acquired FORMULATRIX's digital PCR assets. The deal was valued at USD 260million. This acquisition is in line with the company’s 2020 strategy to launch new digital PCR platforms. It incorporates FORMULATRIX’s advanced dPCR technology.
Bio-Rad Laboratories, Thermo Fischer Scientific Inc., Qiagen N.V., Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMerieux S.A., Fluidigm Corporation are some of the major players in the qPCR/dPCR market. ; and F. Hoffman La Roche.
Report Attribute |
More Details |
2020 market size |
USD 3.0 Billion |
The revenue forecast for 2026 |
USD 4.9 Billion |
Growth Rate |
CAGR of 8.5% between 2019 and 2026 |
Base year for estimation |
2018 |
Historical data |
2014 - 2017 |
Forecast period |
2019 - 2026 |
Quantitative units |
From 2019 to 2026, revenue in USD million and CAGR |
Report coverage |
Forecast revenue; company share; competitive landscape, growth factors and trends |
Segments covered |
Technology, product and application. |
Regional scope |
North America; Europe; Asia Pacific, Latin America; MEA |
Country coverage |
U.S.; Canada; Germany; U.K.; France; Italy; Spain; Russia; China; Japan; India; South Korea; Australia; Singapore; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Bio-Rad Laboratories; Thermo Fisher Scientific Inc.; Qiagen N.V.; Abbott Laboratories, Inc.; Agilent Technologies, Inc.; bioMerieux S.A.; Fluidigm Corporation. ; F. Hoffman La Roche. |
The scope of customization |
With purchase, you get a free report customization (equivalent to up to 8 analysts working day) You can add or modify country, regional and segment scope. |
Prices and purchase options |
You can get customized purchase options that meet your specific research needs. E Shop for xplore |
This report predicts revenue growth at the global, regional and country level and offers analysis of industry trends for each sub-segment from 2014 to 2026. Grand View Research segmented the global real-time PCR market (qPCR), and digital PCR(dPCR) market reports based on technology and product.
Technology Outlook, Revenue, USD Millions, 2014-2026
Quantitative
Digital
Product Outlook (Revenue USD Million, 2014-2026)
Consumables & Reagents
Instruments
Software & Services
App Outlook (Revenue USD Million, 2014-2026)
Clinical
Pathogen Testing
Blood screening
Oncology Testing
Other
Research
Forensic and Other
Regional Outlook (Revenue USD Million, 2014-2026)
North America
The U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Russia
Asia Pacific
China
Japan
India
South Korea
Australia
Singapore
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. Global real-time PCR and digitalPCR market was valued at USD 2.8 Billion in 2019, and is forecast to grow to USD 3.0 Billion by 2020.
What is the real-time pcr growth and digital pcr growth?b. Global real-time PCR and digital market share are expected to increase at 8.4% annually between 2018-2026, reaching USD 4.9 billion in 2026.
Which market segment had the highest real-time pcr or digital pcr market shares?b. Consumables and reagents accounted for more than 65% of the market value in 2019, according to b. This segment is expected to grow at a faster rate than other segments due to the introduction of new PCR testing kits.
What are the major players in the real-time pcr and digital market?b. Bio-Rad Laboratories, Thermo Fischer Scientific Inc., Qiagen N.V., Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMerieux S.A., Fluidigm Corporation are some of the key players in the digital PCR and real-timePCR market. ; and F. Hoffman La Roche.
What are the driving factors for the digital pcr market and real-time pcr?b. The rapid technological advances and high prevalence of target diseases are key factors driving real-time PCR/digital PCR market growth.
Up Market Research published a new report titled “Real-time PCR & Digital PCR Market research report which is segmented by Product (Instruments, Consumables), by Technology (Digital, Quantitative), By Players/Companies Digital, Technology Outlook (Revenue USD Million 2014 - 2026)QuantitativeDigital, Quantitative”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Real-time PCR & Digital PCR Market Research Report |
By Product | Instruments, Consumables |
By Technology | Digital, Quantitative |
By Companies | Digital, Technology Outlook (Revenue USD Million 2014 - 2026)QuantitativeDigital, Quantitative |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 205 |
Number of Tables & Figures | 144 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Product (Instruments, Consumables), by Technology (Digital, Quantitative).
Real-time PCR & Digital PCR Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Real-time PCR & Digital PCR Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Real-time PCR & Digital PCR Market Report:
Some other reports from this category!